Spondyloarthritides
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 25 (6) , 825-842
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Different response to rituximab in tumor necrosis factor blocker–naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty‐four–week clinical trialArthritis & Rheumatism, 2010
- Treatment of ankylosing spondylitis and other spondyloarthritidesCurrent Opinion in Rheumatology, 2009
- Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trialAnnals of the Rheumatic Diseases, 2009
- Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled studyAnnals of the Rheumatic Diseases, 2008
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsNature Genetics, 2007
- Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytesAnnals of the Rheumatic Diseases, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesThe American Journal of Human Genetics, 2007
- Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formationAnnals of the Rheumatic Diseases, 2007
- Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trialAnnals of the Rheumatic Diseases, 2006
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984